Tortoise Investment Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-1,316
| Closed | -$59.4K | – | 387 |
|
|
2025
Q3 | $59.4K | Sell |
1,316
-23
| -2% | -$1.07K | 0.01% | 372 |
|
|
2025
Q2 | $62K | Buy |
1,339
+63
| +5% | +$3.09K | 0.01% | 359 |
|
|
2025
Q1 | $77.8K | Buy |
1,276
+1
| +0.1% | +$58 | 0.01% | 315 |
|
|
2024
Q4 | $72.1K | Buy |
1,275
+3
| +0.2% | +$168 | 0.01% | 352 |
|
|
2024
Q3 | $65.8K | Buy |
1,272
+1
| +0.1% | +$47 | 0.01% | 369 |
|
|
2024
Q2 | $52.8K | Sell |
1,271
-105
| -8% | -$4.7K | 0.01% | 381 |
|
|
2024
Q1 | $74.6K | Buy |
1,376
+1
| +0.1% | +$51 | 0.01% | 327 |
|
|
2023
Q4 | $70.6K | Sell |
1,375
-970
| -41% | -$50.9K | 0.01% | 315 |
|
|
2023
Q3 | $136K | Buy |
2,345
+317
| +16% | +$19.4K | 0.02% | 242 |
|
|
2023
Q2 | $130K | Buy |
2,028
+100
| +5% | +$6.71K | 0.02% | 252 |
|
|
2023
Q1 | $134K | Hold |
1,928
| – | – | 0.02% | 232 |
|
|
2022
Q4 | $139K | Buy |
1,928
+107
| +6% | +$8.07K | 0.02% | 225 |
|
|
2022
Q3 | $129K | Hold |
1,821
| – | – | 0.03% | 221 |
|
|
2022
Q2 | $140K | Sell |
1,821
-115
| -6% | -$8.76K | 0.03% | 198 |
|
|
2022
Q1 | $141K | Buy |
1,936
+115
| +6% | +$7.72K | 0.03% | 206 |
|
|
2021
Q4 | $114K | Sell |
1,821
-270
| -13% | -$15.8K | 0.02% | 208 |
|
|
2021
Q3 | $124K | Sell |
2,091
-133
| -6% | -$8.76K | 0.03% | 189 |
|
|
2021
Q2 | $149K | Hold |
2,224
| – | – | 0.03% | 177 |
|
|
2021
Q1 | $140K | Hold |
2,224
| – | – | 0.03% | 180 |
|
|
2020
Q4 | $138K | Buy |
2,224
+716
| +47% | +$44K | 0.03% | 170 |
|
|
2020
Q3 | $91K | Hold |
1,508
| – | – | 0.02% | 184 |
|
|
2020
Q2 | $89K | Sell |
1,508
-155
| -9% | -$9.27K | 0.02% | 182 |
|
|
2020
Q1 | $93K | Sell |
1,663
-500
| -23% | -$30.6K | 0.03% | 179 |
|
|
2019
Q4 | $139K | Buy |
2,163
+655
| +43% | +$37.5K | 0.03% | 167 |
|
|
2019
Q3 | $76K | Sell |
1,508
-100
| -6% | -$4.7K | 0.02% | 202 |
|
|
2019
Q2 | $73K | Hold |
1,608
| – | – | 0.02% | 216 |
|
|
2019
Q1 | $77K | Sell |
1,608
-1,600
| -50% | -$79.7K | 0.02% | 205 |
|
|
2018
Q4 | $167K | Buy |
3,208
+475
| +17% | +$25.5K | 0.05% | 150 |
|
|
2018
Q3 | $170K | Hold |
2,733
| – | – | 0.04% | 149 |
|
|
2018
Q2 | $151K | Hold |
2,733
| – | – | 0.04% | 156 |
|
|
2018
Q1 | $173K | Buy |
2,733
+233
| +9% | +$15K | 0.05% | 144 |
|
|
2017
Q4 | $153K | Hold |
2,500
| – | – | 0.04% | 149 |
|
|
2017
Q3 | $159K | Buy |
+2,500
| New | +$146K | 0.05% | 142 |
|
|
2017
Q2 | – | Sell |
-50
| Closed | -$3K | – | 491 |
|
|
2017
Q1 | $3K | Hold |
50
| – | – | ﹤0.01% | 416 |
|
|
2016
Q4 | $3K | Sell |
50
-50
| -50% | -$2.73K | ﹤0.01% | 427 |
|
|
2016
Q3 | $5K | Sell |
100
-1,372
| -93% | -$88.1K | ﹤0.01% | 366 |
|
|
2016
Q2 | $108K | Sell |
1,472
-1,200
| -45% | -$84.8K | 0.04% | 129 |
|
|
2016
Q1 | $171K | Buy |
2,672
+100
| +4% | +$6.31K | 0.06% | 111 |
|
|
2015
Q4 | $177K | Hold |
2,572
| – | – | 0.06% | 114 |
|
|
2015
Q3 | $152K | Sell |
2,572
-200
| -7% | -$12.7K | 0.06% | 119 |
|
|
2015
Q2 | $184K | Buy |
2,772
+200
| +8% | +$13.2K | 0.07% | 111 |
|
|
2015
Q1 | $166K | Hold |
2,572
| – | – | 0.06% | 116 |
|
|
2014
Q4 | $152K | Hold |
2,572
| – | – | 0.06% | 125 |
|
|
2014
Q3 | $132K | Sell |
2,572
-1,200
| -32% | -$59.9K | 0.06% | 128 |
|
|
2014
Q2 | $183K | Buy |
3,772
+1,200
| +47% | +$59.1K | 0.08% | 104 |
|
|
2014
Q1 | $134K | Hold |
2,572
| – | – | 0.06% | 117 |
|
|
2013
Q4 | $137K | Hold |
2,572
| – | – | 0.08% | 107 |
|
|
2013
Q3 | $119K | Hold |
2,572
| – | – | 0.07% | 103 |
|
|
2013
Q2 | $115K | Buy |
+2,572
| New | +$112K | 0.08% | 96 |
|
Other funds holding BMY
Tortoise Investment Management's BMY Position: Q4 2025 in Review
Tortoise Investment Management sold out of Bristol-Myers Squibb (BMY) in Q4 2025, closing a stake of 1,316 shares — an estimated $59.4K sold.
Tortoise Investment Management first reported a position in BMY in Q2 2013 and held it in 49 quarters. The position peaked at $184K in Q2 2015. 2,454 funds tracked by Wall St. Rank hold BMY as of Q4 2025.
- Tortoise Investment Management reported no remaining Bristol-Myers Squibb position as of Q4 2025 after selling out during the quarter.
- Tortoise Investment Management sold 1,316 Bristol-Myers Squibb shares in Q4 2025, an estimated $59.4K.
- Tortoise Investment Management first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 49 quarters.
- Tortoise Investment Management's Bristol-Myers Squibb position peaked at $184K in Q2 2015.
- 2,454 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2025.
Based on Tortoise Investment Management's 13F filing for Q4 2025, filed 6 Feb 2026.